Katrina Church Offers 20 Plus Years of Experience: Secures CCO Position at Bioventus

Katrina Church has been appointed chief compliance officer of Bioventus. The news was announced today.

Katrina Church brings more than 20 years of experience counseling public and private companies to ensure the highest compliance with industry standards, reporting and controls. She will be responsible for all ethics and compliance functions at Bioventus, joins the company’s executive leadership team and will report directly to its CEO Ken Reali.

“I am very pleased to welcome Katrina as our new Chief Compliance Officer,” said Reali. “High ethics and compliance standards are paramount to our success and also important to our culture at Bioventus. I expect Katrina to build on the great foundation we have at this company as we continue to expand and grow to meet the needs of patients, physicians and payers.”

Katrina Church joins Bioventus after nearly 11 years with the Merz Group of companies where she served in several corporate counsel and compliance roles, most recently as Global Compliance Officer for Merz Pharma GmbH & Co KGaA. In 2020, Church was nominated for several industry awards for compliance training, and won the 2020 Women in Compliance Award for “Most Impactful Compliance Training Programme of the Year.”

Prior to Merz, Church served as a legal consultant to Stiefel Laboratories and in general counsel and corporate counsel roles with Connetics Corporation and VISX, Inc. She began her career as an attorney at Hopkins & Carley, a San Jose-based law firm. Church received her Juris Doctor from New York University School of Law and an AB magna cum laude from Duke University.

SourceBioventus

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.